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ABSTRACT 
Zona pellucida hardening is a natural process that occurs after oocyte fertilization to prevent 
polyspermic fertilization and to protect embryonic development. Pre-fertilization hardening of 
the zona pellucida however, decreases fertilization rates. Cryoprotectants have also been shown 
to negatively affect fertilization rates, one possible mechanism of which being through zona 
hardening. This experiment was conducted to determine the effect of different cryoprotectants on 
hardening of the zona pellucida using fresh mature bovine oocytes and vitrified mature bovine 
oocytes. Oocytes were post-slaughter from mixed breed cows. After collection, oocytes were 
randomly assigned to three cryoprotectant treatment groups: dimethyl sulfoxide (DMSO), 
glycerol or phosphate buffered saline (PBS-control). Drops (50 l) of each vitrification solution 
were placed under mineral oil. Vitrification solution 1 (VS1) contained 10% ethylene glycol 
(EG), either 10% DMSO or glycerol, and 0.5 M sucrose. Vitrification solution 2 (VS2) contained 
20% EG, 20% DMSO or glycerol, and 0.5 M sucrose. All oocytes were held in VS1 for 5 
minutes before being transferred to VS2 for 45 seconds. All oocytes were washed in a common 
dilution solution (80% PBS, 20% calf serum, 0.025 M sucrose) for 5 minutes. Next, oocytes 
were moved to drops (50l) of protease solution (0.1% protease) under mineral oil. Control 
oocytes were held in PBS for 5 minutes and 45 seconds before entering the dilution solution for 
5 minutes, to represent the same time period as the vitrification procedure.  The oocytes were 
observed until the zona pellucidae were completely digested and times were recorded for each 
oocyte. This protocol was repeated with the vitrified oocytes, which were vitrified in liquid 
nitrogen after exposure to the vitrification solutions. The first experiment using fresh oocytes 
included five replicates with a total of 117 oocytes used, 41 each in DMSO and glycerol and 35 
in PBS. The data were analyzed using LSM and contrasts. The differences between DMSO and 
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glycerol were significant (p = 0.0238) but, the differences between DMSO and PBS were not 
significant (p = 0.3325). However, both the differences between glycerol versus PBS and the 
average of DMSO and glycerol compared to PBS was significantly different (P-value = 0.0058 
and P-value = 0.0262, respectively). The second experiment using vitrified ‘oocytes included 
three replicates with a total of 114 oocytes used, 37 in DMSO, 41 in glycerol and 36 in PBS. The 
data were analyzed using LSM and contrasts. In all of the comparisons, no statistical significance 
was observed (DMSO vs. Glycerol- P=0.5301; DMSO vs. PBS- P=0.1699; Glycerol vs. PBS- P= 
0.3818; and DMSO and Glycerol vs. PBS- P=0.2004). These results show that with fresh 
oocytes, glycerol hardens the zona pellucida more than DMSO or PBS but, there is not enough 
evidence to determine if DMSO hardens the zona pellucida more than PBS. However, with 
vitrified oocytes, cryoinjury proved to be too great to accurately measure zona hardening. These 
data suggest that, in relation to zona hardening, and ensuring proper fertilization, glycerol-based 
cryoprotectants may be a better option than DMSO-based ones. Further, these results may be 
important in embryo vitrification as zona hardening may prevent blastocyst hatching, suggesting 
that glycerol-based cryoprotectants should be investigated as the optimal cryoprotectant here 
also.   
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CHAPTER I 
INTRODUCTION 
 
In vitro embryo production, or IVP, is an inclusive term used to describe all the steps 
used to produce embryos. However, in vitro fertilization, IVF, is frequently used as a general 
term for the process of creating embryos outside of the body, which includes in vitro maturation 
(IVM) of oocytes, in vitro insemination and fertilization of oocytes (IVF) and in vivo culture 
(IVC) of resulting embryos. The steps of IVP are conducted in the sequence IVM-IVF-IVC 
(Hasler and Barfield, 2015). Assisted reproductive technologies, or ART, encompasses all the 
procedures that could be used to complete IVP. In vitro production is an invaluable tool for 
human fertility clinics, as these ART help to increase the chances of subfertile men and women 
having children of their own (Hansen, 2013). Also, in the commercial livestock industry, IVP has 
had many beneficial applications including, but not limited to, improving genetic selection, 
allowing gender selection, and increasing the number of potential offspring per individual. 
Cryopreservation is the use of very low temperatures to preserve structurally intact 
living cells and tissues (Pegg, 2015). Cryopreservation allows the transfer of a limited number 
of fresh embryos back to the uterus and the storage of the remaining embryos for future use, 
thus maximizing the cumulative effectiveness of IVP (Loutradi et. al, 2008). Although there 
are definite benefits to cryopreservation, there are also negative effects. The various steps 
required for cryopreservation may contribute individually or cumulatively to oocyte damage 
which in turn, decrease fertilization and developmental rates (Saunders and Parks, 1999). 
Preventing ice crystal formation during cryopreservation is critical to the developmental 
capacity of the oocyte/embryo. Cryoprotective agents (CPAs) are used to eliminate ice crystal 
formation but, toxicity of CPAs limits the concentrations that can be used (Best, 2015). 
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Vitrification, a form of cryopreservation, has become the industry standard. It does not require 
expensive equipment, uses small amounts of liquid nitrogen, and is not time-consuming. 
However, vitrification requires high concentrations of CPAs that can prevent the 
oocyte/embryo from achieving its full developmental capacity. There is now significant 
evidence that CPAs, despite their benefits, can actually play a direct role in producing 
cryoinjry (Fahy, 1986). One such form of cryoinjury is zona pellucida hardening.  
The overall goal of this research is to determine which cryoprotectant, dimethyl 
sulfoxide (DMSO) or glycerol, has the greatest effect on zona pellucida hardening. Zona 
pellucida hardness, after exposure to cryoprotectant, will be determined by protease digestion. 
This will help determine which cryoprotectant has less of an impact on the zona pellucida.  
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CHAPTER II 
LITERATURE REVIEW 
 
HISTORY 
The accidental discovery by Polge, Smith, and Parkes in 1949, that glycerol would enable 
fowl spermatozoa to survive freezing to -70°C, making the fowl spermatozoa the first 
mammalian reproductive cells to be successfully frozen, initiated a phase of dramatic 
development in the techniques we now know as cryopreservation (Polge et al., 1949). Prior to 
Polge, Smith, and Parkes discovery, the field of cryopreservation had been limited to 
descriptions of cellular and tissue behavior of many different cell types at subphysologic 
temperatures (Walters et al., 2009). The first human birth from frozen sperm was reported in 
1953 (Sherman, 1973). Improvements in the efficiency of cryoprotectants and discoveries of new 
ones, led to the first human birth from a frozen embryo in 1984 (Trounson et al., 1983) and the 
first human birth from a frozen oocyte in 1986 (Chen, 1986). Subsequent modifications of 
cryopreservation techniques resulted in the introduction of cryopreservation as a standard 
method offered by virtually every full-service IVF program worldwide (Valojerdi et al., 2009). 
The most common method during that time period of cryopreservation was slow rate freezing. 
Currently, cryopreservation via vitrification is considered the only alternative to long-term 
preservation of large-sized biological specimens (Eisenberg et al., 2014). Since such high 
concentrations of CPAs are required for cryopreservation, cryoinjury occurs at high rates. 
Studies have raised concerns regarding potential fertilization of cryopreserved mature oocytes 
following observations of physical damage (Gook, 2011) and structural modifications to the zona 
pellucida (Todorow et al., 1989). Incidence of cryoinjuries depends on the size and shape of the 
cell, the permeability of the cell membranes, and the quality of the cells. However, these factors 
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differ between species, developmental stage and origin (Vajta and Kuwayama, 2006). Successful 
cryopreservation of spermatozoa and embryos has made ART more practical and available for 
commercial use (Baldassarre and Karatzas, 2004).  
OOGENESIS 
 Oogenesis, the differentiation of the ovum, is a complex process that starts during fetal 
development (Harper, 2001). Primordial germ cells develop from the inner lining of the fetal 
yolk sac and migrate to the genital ridge (Senger, 2005). In the developing ovary, these 
primordial germ cells divide by mitosis, or rapid proliferation, to form a population of oogonia 
(Feher, 2012). At the end of mitotic proliferation, the oogonia enter meiotic prophase and 
differentiate into primary oocytes (Miyamoto and Gurdon, 2013). Development of the primary 
oocyte is arrested in prophase I of meiosis and remains in this state until the onset of ovulatory 
cycles at puberty (Szmelskyj and Aquilina, 2015). During this period, oocytes accumulate a 
stockpile of macromolecules and organelles that are required to support early embryonic 
development (Miyamoto and Gurdon, 2013). Meiotic progression seems to be an integral part of 
oogenesis, since a number of proteins are required for both meiotic progression and for the 
development of functional oocytes (Maine, 2001). Each oocyte is contained within a cellular 
follicle that grows concomitantly with the oocyte, from a single layer of a few epithelial-like 
cells to three layers of cuboidal granulosa cells by the time the oocyte has completed its growth 
(Wassarman, 2001). A relatively high degree of synchronization appears to be a general feature 
of mammalian oocytes since the germ cells mature in groups, each of which consists of the 
elements at an identical stage of differentiation (Miyamoto and Gurdon, 2013). This 
synchronization is made possible by the presence of cytoplasmic bridges connecting the cells in 
each group to one another and bringing about a syncytial organization. The frequency of which 
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these bridges are found in the thin sections of embryonic ovarian tissue in electron microscopy 
indicates that their actual number is very high and that they form a network of intracellular 
connections which results in the organization of the germ cells into multiples syncytial groups 
(Zamboni, 1972).  During all developmental stages, oogonia, oocytes and follicles may become 
atretic and die (Byskov and Anderson, 2013). At birth, the human ovaries contain in excess of 2 
million primary oocytes which enlarge gradually to become the single largest unicellular cell in 
the body. However, over the reproductive lifespan, a woman will typically only ovulate 400-500 
of those primary oocytes due to atresia of the remainder (Feher, 2012). 
 Once puberty, the ability to accomplish reproduction successfully, has been reached 
(Senger, 2015), a gonadotropin surge stimulates a luteinizing hormone (LH) surge. The 
completion of meiotic maturation results in response to the LH surge, emitting the first polar 
body, subsequently becoming an unfertilized egg. Upon fertilization by sperm, the ovulated egg 
completes the second meiotic division, with separation of chromatids and extrusion of a second 
polar body (Wassarman, 2001). 
 Two types of cells in particular play major roles in oogenesis: mural granulosa cells and 
cumulus cells. Apart from anatomical differences, mural granulosa cells and cumulus cells are 
functionally distinct (Rong et al., 2000). Granulosa cells line the follicle and support the growth 
of the follicle. They are responsible for the conversion of androgens to estrogens, as well as 
progesterone synthesis (Havelock et al., 2004). The granulosa cells of the ovulatory follicle are 
the major and virtually only source of estradiol in the follicular phase of the ovarian cycle and 
secrete estrogens in response to follicle stimulating hormone (FSH) (Goodman, 2009).  After the 
LH surge, the granulosa cells produce epidermal growth factors that act on cumulus cells to 
induce cumulus cell expansion and oocyte maturation (Hung et al., 2015). Conversely, cumulus 
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cells surround the oocyte and are in intimate metabolic contact with the oocyte (Rong et al., 
2000). Cumulus cells regulate oocyte growth, oocyte maturation and the fertilization process (Da 
Costa et al., 2015). Also, expansion of the cumulus-oocyte complex is necessary for meiotic 
maturation and acquiring developmental competence (Nevoral et al., 2015). The cumulus cells 
and the oocyte make up the cumulus-oocyte complex (COC). The COC is connected by gap 
junctions between the cumulus cells and also between the cumulus cells and the oocyte. Gap 
junctions between cumulus cells and oocytes are thought to be essential for oocyte maturation 
and fertilization (Zhou et al., 2016) and they allow a rapid transfer of small metabolites and 
regulatory molecules from the cumulus cells into the oocyte (Van Soom et al., 2002).  
COLLECTION 
In the history of oocyte collection, several methods have been employed: surgical, 
laparoscopic, abattoir ovaries, and oocyte pick-up via transvaginal guided follicular aspiration. 
Surgical and laparoscopic methods have become outdated in cattle due to their high cost and low 
oocyte recovery numbers (Pawshe et al., 1994), long recovery period for the animal, and overall 
time it takes to complete these procedures. In human fertility, the main disadvantage of 
laparoscopic collection lies in the necessary use of general anesthesia, the limitation of access to 
adherent or covered ovaries and its common post-operative abdominal discomfort and 
hospitalization stay of 6-24 hours (Leeton, 1989). Oocyte collection from an abattoir has become 
the most common collection method. The oocytes can be obtained relatively easily and 
inexpensively (Das et al., 1996) and it produces the most abundant source of primary oocytes 
(Wang et al., 1996). Neglia and colleagues determined that a higher proportion of Grade A 
oocytes are recovered from abattoir derived ovaries compared to transvaginal ultrasound guided 
aspirated oocytes, possibly due to the fact that greater mechanical damage is induced to 
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granulosa cells during the oocyte pick-up procedure (Neglia et al., 2003). In a study conducted 
by Souza-Fabjan and colleagues, they determined that oocyte pick-up derived oocytes require 
more time to mature when submitted to maturation media, have lower cleavage potential, and 
were less advanced in meiosis than abattoir derived oocytes (Souza-Fabjan et al., 2014). 
However, due to collection from abattoirs’ terminal nature, this method cannot be repeated 
(Hashimoto et al., 1999).  
Oocyte pick-up via transvaginal ultrasound guided follicular aspiration (TUGA) has 
shown to be a reliable method for oocyte retrieval (Bols et al., 1996). It can be performed twice 
weekly without side effects on the animals’ reproductive career (Galli et al., 2013). To begin 
TUGA, the cow must be contained in a chute to ensure as little movement as possible, with an 
epidural anesthesia administered to prevent abdominal straining (Pieterse et al., 1991) and ease 
of handling the ovaries through the rectum (Galli et al., 2013). After emptying the rectum and a 
thorough cleaning of the vulva and perineal area (Garcia and Salaheddine, 1998), the vaginal 
probe is inserted into the vagina adjacent to the cervix, and after retraction of the uterus, the right 
or left ovary is placed against the head of the transducer. The antral follicles appear as 
hypoechoic round structures on the ultrasound monitor and an ultrasound needle guide may or 
may not be used to aspirate the imaged follicles (Pieterse et al., 1991). The transducer is 
positioned so that the needle guide on the ultrasound monitor transects the follicle to be aspirated 
and the needle is pushed through the vaginal wall into the follicle (Pieterse et al., 1988). The 
follicular fluid is aspirated using continuous negative pressure applied by an electronic suction 
pump. The needle itself is connected to silastic tubing so that the contents of the aspirated follicle 
are collected in a tube vial (Garcia and Salaheddine, 1998). After the needle is withdrawn from 
the ovary and the probe from the vagina, the needle and silastic tubing is flushed with phosphate-
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buffered saline (PBS). The fluid aspirated from the follicles is filtered and inspected for oocytes 
(Pieterse et al., 1991). The combination of TUGA and IVP enables the acceleration of genetic 
improvement for production traits and provides the basis for more advanced technologies (Aller 
et al., 2010). By employing TUGA heavily in livestock species, it has provided decades of 
knowledge for assisted reproduction techniques that have been translated to innumerable 
advancements in the human fertility field (Galli et al., 2013).  
CRYOPRESERVATION 
 Cryopreservation is the process of freezing biological material at extremely low 
temperatures; most commonly -196 degrees Celsius in liquid nitrogen. At these low 
temperatures, all biological activity ceases, including the biochemical reactions that lead to cell 
death and DNA degradation. During freezing, all cells go through the steps of temperature 
reduction, cellular dehydration, freezing and thawing, respectively. The accidental discovery, 
made by Polge, Smith, and Parkes, of the cryoprotective properties of glycerol revolutionized the 
cryopreservation field and sparked an abundance of further research (Polge et al., 1949). This 
landmark study also identified the fine balance between the protection and toxicity associated 
with the use of glycerol and other cryoprotectants such as propylene glycol and ethylene glycol 
(Gook, 2011). However, regardless of cryoprotectant use, some cryoinjury is still unavoidable 
due to the fact that each cell type responds differently to cryoprotectants and cryopreservation. 
Optimal protocols have not been established for each. The extent of the injury depends on factors 
including size and shape of the cells, the permeability of the membranes and the quality and 
sensitivity of the cells, oocytes, and embryos. All these factors may be highly variable depending 
on species, developmental stage and origin (Vajta and Kuwayama, 2006). Things that also must 
be considered during cryopreservation are transmembrane fluxes associated with the addition 
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and removal of CPAs, the change in chemical potentials during cooling and warming, both 
intracellular and extracellular ice formation, the effects of cooling and warming rates and storage 
temperatures, and heat transfer in solutions and tissues (Walters et al., 2009). Nonetheless, the 
main key to successful cryopreservation of any cell type is to avoid ice formation inside cells 
(Godsen, 2011). Understanding and controlling water permeability during cooling and thawing is 
crucial to minimizing cryoinjury. To prevent intracellular ice formation, or minimize the damage 
it can cause, all commonly used cryopreservation protocols for oocytes are designed to dehydrate 
them (Shaw et al., 2000). Cells have osmotic tolerance limits to which they can shrink or swell 
during cryopreservation, without significant damage. The formation of ice crystals hinders the 
cell from being able to shrink (Walters et al., 2009). At temperatures at or below 0 degrees 
Celsius, water resists the breaking of hydrogen bonds and the molecules lock together in a 
lattice-like symmetry, creating pockets of “open space”, allowing ice crystal formation. Ice 
nucleation, the point at which ice crystal growth is initiated, has the ability to grow and spread 
rapidly throughout the cell (Benson, 2008). Cryoprotectants, acting through increasing the total 
concentration of all solutes in the system, reduce the amount of ice formed at any given 
temperature. Providing water can leave the cells rapidly to maintain thermodynamic equilibrium 
across the cell membrane, the cytoplasm will not cool below its freezing point and all the ice will 
be external to the cells (Pegg, 2007).  The probability of intracellular freezing is minimized by 
the cooling rate and the permeability of the cells to water (Pegg, 2010). Two types of 
cryopreservation exist: slow-rate freezing and vitrification. Slow rate freezing allows the cell to 
be able to lose water by exosmosis, avoiding intracellular freezing, while in vitrification, the cell 
is not able to lose water at a rate that maintains osmotic equilibrium. The cell becomes 
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supercooled in vitrification, eventually reaching equilibrium by forming a glass-like structure 
intracellularly (Alink and Offerings, 1977).  
 Cryopreservation of oocytes and embryos has become an integral part of improving the 
success rate of infertility treatment (Kuleshova and Lopata, 2002). It has increased the efficiency 
of ART procedures, allowing for the conservation of biodiversity, and providing a way to 
preserve rare and valuable biological material. The acceptance of oocyte and embryo 
cryopreservation in general assisted reproduction practice has finally come to fruition and has 
now arrived at a stage where it is considered to be routine (Gook, 2011). 
CRYOPROTECTANTS 
 Cryoprotective agents (CPAs) are small, water-soluble molecules that serve as colligative 
antifreeze agents by disrupting hydrogen bonds between water (Godsen, 2011). In 1949, Polge 
and colleges discovered that the use of glycerol as a cryoprotectant greatly increased the 
proportion of human spermatozoa that could be revived after cryopreservation. Their subsequent 
experiments all suggested that a high proportion of water could be withdrawn from cells at low 
temperatures with ensuing restoration of structure and function of the cell (Polge et al., 1949). 
The effectiveness of a cryoprotectant depends on a number of properties: 1) the compound must 
be highly soluble in water and remain so at low temperatures in order to produce a profound 
depression of the freezing temperature; 2) it must be able to penetrate into the cells; and 3) must 
have low toxicity so that it can be used in the high concentrations that are required to produce the 
cryopreservative effects (Pegg, 2007). Cryoprotectants are divided into two main classes: 
permeating and non-permeating. Permeating CPAs penetrate the cell membrane and prevent ice 
crystal formation and membrane rupture, whereas non-permeating CPAs do not penetrate the cell 
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membrane and act by reducing the hyperosmotic effect during the freezing procedure (Janz et al., 
2012).  
 In cryopreservation protocols, commonly used permeating cryoprotectants are dimethyl 
sulfoxide (DMSO), ethylene glycol (EG), propylene glycol (PG) and glycerol (GLY), with 
glycerol being the most frequently used. They are small, cell membrane penetrating molecules 
that act by increasing membrane fluidity through rearrangement of membrane lipid and proteins, 
resulting in greater dehydration at lower temperatures and reduced intracellular ice formation 
(Holt et al., 2000). The criteria for a permeating cryoprotectant is that the compound must 
penetrate the cell, otherwise it will dehydrate the cell osmotically and stimulate freezing injury, 
and it must be non-toxic in the multimolar concentrations that are necessary to prevent excessive 
ice formation. The rate at which these compounds enter cells varies not only with the agent, but 
with the type and origin of the cell (Meryman, 1971). For example, a study conducted by Hober 
and colleges showed that the penetration rate of glycerol into the red blood cells of a variety of 
mammals, is highest among rats and men, and 200 times slower in the sheep (Hober et al., 1945). 
The permeating cryoprotective agent is traditionally associated with protection against slow 
freezing injury; it prevents injury simply by reducing, on a purely colligative basis, the amount 
of ice formed, thereby reducing the concentration of non-permeating solute needed (Meryman, 
1971). The potential for adverse events or reactions is heavily skewed towards permeating CPAs, 
since these are more able to interact directly with a multitude of cellular activities, such as 
enzymatic processes, transporter mechanisms, ion exchanges and the like (Elliot et al., 2017).   
 Non-permeating cryoprotectants are the second class of cryoprotectants. Some of the 
frequently used non-permeating cryoprotectants are sucrose, trehalose, dextrose, and 
polyvinylpyrrolidone, with sucrose being the most commonly used. These cryoprotectants do not 
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penetrate the cell membrane, are high in molecular weight, hydrophilic, and act by helping a cell 
stabilize its concentration of internal solutes under osmotic stress (Cleland et al., 2004). Because 
of their inability to diffuse across the plasma membrane, non-permeating cryoprotectants create 
an osmotic pressure that lowers the freezing temperature of the medium and decreases 
extracellular ice formation (Aisen et al., 2002). Osmotic stress occurs when the extracellular 
solute concentration is too high and water rapidly leaves the cell, causing harm to the structure 
and function of the cell. However, if not enough water is removed from the cell, intracellular ice 
formation will occur and possibly cause the cell to lyse during the thawing process. 
 The processes of diffusion and osmosis have important effects during the introduction of 
cryoprotectants, the removal of cryoprotectants, the freezing process and during thawing (Pegg, 
2007). Depending upon which type of cryoprotection used, either slow rate freezing or 
vitrification, the effects of diffusion and osmosis are different. In 1963, Mazur discovered that 
the rate of change of temperature was also important because it controlled the transport of water 
across the cell membrane, and hence, indirectly, the probability of intracellular freezing (Mazur, 
1963). The toxicity of cryoprotectants to cells is another major concern. The toxicity of 
cryoprotectants limits the concentration of additive that can be used before freezing and 
therefore, limits the cryoprotective efficacy of these agents. With high enough concentrations of 
cryoprotectants, damaging factors can be suppressed (Fahy, 1986). However, the concentration 
needed for complete suppression is often too high, causing injury rather than protection (Fahy, 
2010). Therefore, cryoprotectant toxicity is the single most limiting factor for the success of 
cryopreservation by both slow rate freezing and vitrification and for the scope of cryobiological 
protocols (Fahy, 1987). Typically, to limit toxicity and to best cryopreserve cells, a combination 
of permeating and non-permeating cryoprotectants are used in most protocols. However, the 
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ways in which the various cryoprotectants, and their combinations, affect a given cell type 
cannot be predicted, and hence, the selection of cryoprotectants for each type of cell is still 
largely dependent on an empirical and experimental approach (Fan et al., 2009). 
SLOW RATE FREEZING 
 Slow rate freezing, which is considered an equilibrium approach, allows cells to be 
cooled to very low temperatures while minimizing intracellular ice formation, and at the same 
time, attempting to minimize detrimental influences of increased solute concentrations and 
osmotic stress (Friedler et al., 1988). Most importantly, it attempts to control the biophysical 
properties of freezing, like cooling and warming rates (Smith et al., 2010). The success of slow 
rate freezing depends on achieving the optimal balance between the rate at which water can leave 
a cell and the rate at which it is converted to ice (Shaw et al., 2000). Through the use of a 
programmable cooling machine that is controlled by a computer program, the rate at which the 
cells are cooled is controlled within an internal chamber. The exact freezing rate and temperature 
can be programmed by the researcher, providing optimal species specific cellular dehydration. 
Instead of intracellular ice formation, slow rate freezing leads to extracellular ice formation. A 
consensus has developed that intracellular freezing is dangerous, whereas extracellular ice is 
harmless (Pegg, 2007). After cells are placed in a permeating cryoprotectant solution, the 
temperature is then lowered by the cooling machine and ice crystal growth is initiated. As the ice 
crystals grow, water in the solution is converted from its liquid state to a solid state, which 
increases the concentration of solution, and therefore, draws water out of the cells (Shaw et al., 
2000). Water migrates out of the cell in efforts to maintain osmotic equilibrium. After the 
cooling temperature has been lowered to freezing range, cells are plunged into liquid nitrogen 
and stored until thawing. A commonly used protocol, used in a study by Cao and colleagues, for 
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slow rate freezing begins at 25 C. Cooling is started at a rate of -2 C per minute. At -7 C, 
seeding is performed by touching the side of each straw with forceps that have been cooled in 
liquid nitrogen. The straws are held at -7C for 10 minutes and are cooled at a rate of -0.3C per 
minute to -33C before being plunged into liquid nitrogen and stored for later use at -196C (Cao 
et al., 2009). The consequences of slow rate freezing have been documented to include cellular 
injury, resulting in cell death, especially from -15C to -30C (Djumwantono et al., 2011). 
However, other studies, like the study by Sinha and colleagues, show approximately 85% of 
slow rate cryopreserved mature oocytes had normal morphological characteristics after thawing 
(Sinha et al., 2014). Slow freezing has the advantage of using low concentrations of 
cryoprotectants, which are associated with chemical toxicity and osmotic shock (Arav, 2014). 
While many consider slow rate cryopreservation an acceptable approach to cryopreservation, 
recent advances in vitrification have made it the method of choice when cryopreserving oocytes 
and embryos.  
VITRIFICATION 
 Vitrification is the production of a glassy state that is defined by the viscosity reaching a 
sufficiently high value to behave like a solid, but without any crystallization (Pegg, 2007).  
Vitrification was first proposed for cryobiology applications by Luyet in 1937 (Luyet, 1937), but 
the avoidance of ice in tissues were based on the early work of Rall, Fahy and colleagues (Fahy 
et al., 1984; Rall and Fahy, 1985; and Rall, 1987). Unlike slow rate freezing, vitrification offers 
the ability to control the solute penetration, the dehydration rate, and the maintenance at 
physiological temperature during the non-equilibrium procedure (Al-Azawi et al., 2013). The use 
of non-permeating cryoprotectants is very useful because the shrinkage of the oocyte and 
consequently the amount of water inside the cell that may crystallize during rapid cooling and 
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warming is lower (Rall et al., 1987) and because this reduces the amount of the cryoprotectant 
that penetrates the cell thus reducing the possible toxic effect (Szell and Shelton, 1987). Most 
vitrification protocols use solutions with high concentrations of solutes, which rapidly draw 
water out of cells. Usually, vitrification requires molar concentrations of threefold or fourfold 
higher than slow rate freezing, and a very rapid rate of cooling cells below the glass transition 
temperature (Tg) (Godsen, 2011). Both the cooling and warming rates, as well as the composition 
and concentration of the solution will influence how much, if any, ice will form (Kuleshova et 
al., 1999, Shaw et al., 1999, and Vajta et al., 1998). The high cooling rates applied during 
vitrification provide a unique benefit compared to traditional slow rate freezing: the possible 
partial and sometimes total elimination of chilling injury, as the sample passes through the 
dangerous temperature zone quickly enough to disallow sufficient time for damage to develop. 
Vitrification is the most appealing cryopreservation protocol because it takes very little time and 
requires no expensive equipment (Walters et al., 2009). As stated before, most vitrification 
protocols combine the use of both permeating and non-permeating cryoprotectants to achieve the 
best results. The combination of ethylene glycol and dimethyl sulfoxide with sucrose was 
reported for mouse and bovine embryos in 1993 and formed the basis of vitrification protocols 
(Ishimori et al., 1993). Before entering the protocol, oocytes are typically placed in holding 
medium of HEPES-buffered TCM 199, with bovine serum albumin (BSA) or bovine calf serum 
(BCS), and an antibiotic. Gentamicin is routinely used because it is a broad-spectrum antibiotic 
(Dowglish et at., 2017). Many protocols commonly use a stepwise addition of cryoprotectants in 
efforts to slowly equilibrate oocytes and embryos. The first solution, the equilibration solution, 
contains low concentrations of cryoprotectants, usually 10%. With each solution thereafter, the 
concentration of cryoprotectants are gradually increased. The amount of time the oocyte spends 
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in each vitrification solution is dictated by the concentrations of the solution. The higher the 
concentration, the less time the cells are exposed to the solution and vice versa. Exposure for 5 
minutes in equilibrium solution, or vitrification solution 1, then 45 seconds for vitrification 
solution 2, is a protocol used to vitrify bovine oocytes and embryos.  Next, the oocytes are 
loaded on a cryopreservation tool. Of the tools used, the most common are open pulled straw, 
cryoloop, cryotop, and cryolock. The cryolock has become the preferred tool because its 
rectangular, four flat surfaces, and concave tip make it much easier to handle and takes fewer 
steps to load or remove oocytes than the other tools. Also, the cap of the cryolock makes it a  
 
Table 2.1- A Comparison of Vitrification with Slow-Freezing Procedures (From Kuleshova, 
2002). 
 
Accessibility and regulation Vitrification Slow freezing 
Can be observed yes no 
Can be analyzed yes no 
Interaction with the oocyte or embryo yes no 
Control of solute penetration yes no 
Control of dehydration rate yes no 
Maintenance of physiological temperature during 
equilibration procedure 
yes no 
Duration out of incubator ~10 min ~3 h 
Prolonged temperature shock no yes 
Interference with oocyte or embryo low high 
Fracture of the zona pellucida no possible 
Capture by growing ice crystals no possible 
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closed system, preventing pathogen transfer. 
If performed correctly, vitrification does not have any of the biologically damaging  
effects associated with freezing because no appreciable degradation occurs over time in living 
matter trapped within a vitreous matrix. Complete vitrification should eliminate concerns for the 
known damaging effects of intra- and extracellular crystallization that leads to loss of cell 
viability, tissue morphology, extracellular matrix integrity, and RNA degradation (Brockbank et 
al., 2014). When comparing the advantages and disadvantages of vitrification with slow rate 
freezing, vitrification is clearly the superior method. In one study by Li and colleagues, the 
results showed that more human blastocysts survived with higher DNA-integrity index after 
vitrification/warming than after slow freezing/thawing (Li et al., 2012). Cao and colleagues 
conducted a study where slow freezing and vitrification were compared with evaluation of 
survival, early embryonic development, fertilization, meiotic spindle assembly and chromosome 
alignment in frozen thawed human oocytes. In all areas of evaluation, better results were 
achieved with vitrification (Cao et al., 2009).  Even though both procedures are still used today, 
vitrification appears to be the fastest, most efficient and economical approach for oocyte 
cryopreservation.  
WARMING 
The thawing and rewarming process after the storage of oocytes and/or embryos is 
critical to the survival rate (Schellander et al., 1994). As previously mentioned, when going 
through the process of freezing/cooling, cells shrink due to osmotic dehydration. Upon 
thawing/rewarming, water must reenter the cells and cryoprotectants must be removed, causing 
the cell to swell. However, if intracellular ice formed during cryopreservation, upon thawing, it 
will return to water and the cell with have a greater water volume than its normal physiological 
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volume, and the cell could swell to the point to lysing. Because cells are generally more sensitive 
to swelling than to shrinking, removal of cryoprotectants tends to be more hazardous than their 
addition (Pegg, 2007). Diluting cells directly into isotonic solutions inevitably results in a 
significant uptake of water by the cells, which, in extreme cases, can destroy homeostatic 
mechanisms, including membrane barrier characteristics (Elliot et al., 2017). Because of this, as 
in vitrification, a stepwise removal of cryoprotectants is preferred. Agents such as sugars can 
assist in mitigating influx of water into CPA loaded cells upon dilution (Elliot et al., 2007). 
Rewarming must also be ultra-rapid to avoid ice nucleation (Godsen, 2011). Samples are 
transferred from storage in liquid nitrogen (LN2) to a holding reservoir filled with LN2 in 
preparation for the warming procedure. A thawing solution is warmed to 37C either in an 
incubator without CO2 or on a warming plate. A commonly used protocol for warming oocytes 
and/or embryos begins with removal of the samples from the holing reservoir of LN2 and 
immediately plunging them into the warmed thawing solution, where it remains for 1 minute. 
The oocytes are then transferred to a dilution solution for 4 minutes and then to two separate 
wash solutions for 4 minutes each (Irvine Scientific). A rule of thumb is that cells should be 
thawed quickly and diluted slowly. 
ZONA PELLUCIDA/ ZONA HARDENING 
 The zona pellucida is a thick, translucent, extracellular matrix that surrounds the 
developing oocyte and early embryo. The zona pellucida supports communication between 
oocytes and follicle cells during oogenesis, protects oocytes and embryos during development, 
and regulates interactions between ovulated oocytes and free-swimming sperm during and 
following fertilization. Also, the zona pellucida serves as a barrier to polyspermic fertilization: 
the fertilization of the oocyte with more than one sperm (Wassarman et al., 1999). Three 
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glycoproteins make up the zona pellucida: zona proteins 1, 2, and 3 (ZP1, ZP2, and ZP3). Zona 
proteins 1 and 2 are structural proteins providing structural integrity to the zona. ZP3 is much 
like a receptor for a hormone: it binds to proteins on the spermatozoal membrane (Senger, 2005). 
The zona pellucida is composed of long interconnected filaments that are polymers of ZP2 and 
ZP3, crosslinked by ZP1 to create a three-dimensional matrix (Wassarman et al., 1999).  
A current problem with oocyte cryopreservation is the induction of a primary activation event, 
zona hardening, which specifically inhibits IVF (Matson et al., 1997) and may affect subsequent 
implantation. The process of zona hardening, which is essential for normal development after 
fertilization, can prevent fertilization when it occurs prematurely (Larman et al., 2006). Zona 
hardening is brought about by the fusion of cortical granules to the plasma membrane and the 
release of their contents into the zona pellucida layers (exocytosis) (Sun, 2003). The membrane 
fusion event is calcium-dependent and is normally triggered by the increase in intracellular 
calcium initiated by sperm-egg fusion (Kline and Kline, 1992). However, it has been 
documented that oocyte and/or embryo exposure to cryoprotectants during cryopreservation 
causes a rise in intracellular calcium, prematurely inducing the cortical granule reaction. Morley 
and Whitfield reported that DMSO caused an intracellular calcium rise in various cell lines 
(Morley and Whitflield, 1993). Premature cortical release has been observed after 
cryopreservation in both mouse and human oocytes (Mavrides and Morroll, 2005), but this 
phenomenon has not been studied in the bovine (Fuku et al., 1995). The premature release 
ultimately disrupts the timing of the process and increases the rate of polyspermy and 
subsequently of polyploidy (Fuku et al., 1995). Zona hardening can be overcome in most species 
by intracytoplasmic sperm injection (ICSI) (Porcu et al., 2000) but the fact that the oocyte has 
undergone the cortical granule reaction, indicates that the oocyte has been artificially activated 
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prior to actual fertilization and possible down-regulation of cell cycle control proteins has 
occurred (Larman et al., 2006). If fertilization is successful after zona hardening, many embryos 
encounter implantation failure. Failure of the embryonic zona pellucida to rupture following 
blastocyst expansion is regularly attributed to premature zona hardening. In order to help 
embryos escape from their zonae, different types of assisted hatching have been developed, with 
laser-assisted hatching being the most favored. In vitro studies with both mouse and human 
embryos have indicated that an artificial gap in the zona pellucida significantly improves the 
hatching ability of blastocyst grown in vitro as compared to non-micromanipulated embryos (De 
Vos and Steirteghem, 2000).  
 In many agricultural species, ICSI is not a feasible option to overcome zona pellucida 
hardening. ICSI of bovine oocytes is not effective, unlike in human and mouse oocytes, because 
bovine oocytes are not activated easily by the injection procedure, and therefore, successful 
fertilization rates can be as low as 3%. Bovine oocytes can be activated by ionomycin or 6-
dimethylaminopurine (DMAP) to improve cleavage rates up to 70% (Mavrides and Morroll, 
2005). However, a signification problem arises when activating the oocyte with ionomycin or 
DMAP: these compounds induce parthenogenetic activation, the growth and development of the 
embryo without any actual paternal contribution, which can be as high as 40%, and is a source of 
error in studies (Chung et al, 2000). Overall, IVF yields better cleavage rates than ICSI for 
bovine studies (Mavrides and Morroll, 2005). Zona hardening is often overlooked in many 
species where ICSI can circumvent the hardening. However, since ICSI is time consuming, 
requires expensive equipment and a high level of skill to master the technique, and has low 
success rates in bovine, zona hardening has a more significant impact on the overall fertilization 
process and should be studied in greater detail. 
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CURRENT ISSUES FOR FUTURE RESEARCH 
 Successful cryopreservation of bovine oocytes has major implications in agriculture for 
commercial use. It allows long-distance transportation, omission of estrous synchronization, and 
adds advantages to oocyte banking to preserve valuable female genetic resources. However, in 
bovine species, the low fertilization rates and developmental competence of cryopreserved 
oocytes still needs to be improved (Hwang and Hochi, 2014). Since the efforts to combat zona 
pellucida hardening of cryopreserved oocytes by intracytoplasmic sperm injection in the bovine 
have been mostly unsuccessful, more research needs to be conducted in the area of the causation 
of zona hardening, in particular, the premature intracellular calcium rise and subsequent cortical 
granule reaction due to the exposure of oocytes to cryoprotectants.  
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CHAPTER III 
VITRIFICATION OF MATURE BOVINE OOCYTES 
 
INTRODUCTION 
 Cryopreservation is an integral component of the cattle embryo transfer industry and is 
used to transport genetically superior breeds internationally. Vitrification has become a 
competitive alternative to slow rate freezing (Vajta and Kuwayama, 2006). It is most appealing 
because it is so fast and requires no expensive equipment (Walters, 2009). However, the high 
concentrations of cryoprotectants necessary for vitrification can be toxic to the oocytes, 
therefore, causing it to fail to resume normal structure and function upon thawing. Special 
cytological features of mature oocytes, namely the meiotic spindle, cortical granules and 
cytoskeleton, are thought to be susceptible to damage during cooling and exposure to 
cryoprotectants (Rall, 1992). Dimethyl sulfoxide was proposed as a cryoprotectant in 1960 by 
Lovelock and Bishop and was rapidly shown to have far more widespread applicability than 
glycerol (Lovelock and Bishop, 1959). The use of different cryoprotectants, such as glycerol, can 
also affect the viability of each specific cell type following the freezing and warming process. 
Even though the oocytes may survive cryopreservation, many fail to fertilize or cleave (Mavrides 
and Morroll, 2005). Exposure of oocytes to cryoprotectants prior to freezing causes a significant 
premature exocytosis of cortical granules, which stimulates zona hardening (Fuku, 1995). The 
premature cortical reaction could explain the poor efficiency of oocyte freezing because the 
oocyte has already begun its activation events and possible down regulation of cell cycle control 
proteins (Larman et al., 2006). Zona hardening has been shown to cause a reduction in 
fertilization rates and a disturbance in the organization of the cytoskeleton and metaphase plate 
(Fuku, 1995). Since intracytoplasmic sperm injection is largely unsuccessful in the bovine 
species, zona hardening is detrimental during the cryopreservation of bovine oocytes.  
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 The objective of these experiments was to determine the effects of cryoprotectants on 
premature zona pellucida hardening using fresh oocytes and also, to determine the effects of 
cryoprotectants on premature zona pellucida hardening using vitrified oocytes. The specific aims 
were to compare the effect of dimethyl sulfoxide or glycerol on zona hardening using fresh 
oocytes and to compare the effect of dimethyl sulfoxide or glycerol on zona hardening using 
vitrified oocytes. It was hypothesized that glycerol would harden the zona pellucida more than 
dimethyl sulfoxide and also, that dimethyl sulfoxide would harden the zona pellucida more than 
the control (Dulbecco’s phosphate-buffered saline). 
MATERIALS AND METHODS 
 Unless otherwise stated, all chemicals were obtained from Sigma-Aldrich Chemical Co. 
(St. Louis, MO, USA). 
 Experimental Design 
 Oocytes from mixed breed cows were obtained from abattoir derived ovaries through a 
commercial source and shipped overnight in maturation media consisting of supplemented M199 
(Appendix B). After 22 hours of maturation, the oocytes were immediately placed in the 
vitrification protocol. A total of 117 fresh mature oocytes were used in experiment 1 (n=117) and 
113 vitrified mature oocytes were used in experiment 2 (n= 113). Oocytes were randomly 
assigned to treatment groups: DMSO, glycerol, or the control (DPBS).  
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Table 3.1 Flowchart of Experimental Design 
Collection 
   
 
Maturation 
     
 
Vortexing in Hyaluronidase 
    
 
Vitrification Solution 1 
 
 
Vitrification Solution 2 
                  
 
    Dilution Solution Cryolock/Vitrification 
 
 
          Dilution Solution 
                              
 
 
Thawing Solution 
    
 
Protease Solution 
 
 Experiment One Design 
 Oocytes were shipped in supplemented maturation media M199 and allowed to mature 
for 22 hours within a 5% CO2 incubator. After 22 hours, they were vortexed in 1 mg/mL 
hyaluronidase solution to remove cumulus cells and placed in a warmed holding medium, 
HEPES-TALP (Appendix B), until entering the vitrification protocol. Oocytes were first exposed 
to a 50 L drop of vitrification solution one (Appendix B) under mineral oil and remained there 
for 5 minutes. Immediately afterwards, the oocytes were transferred to a 50 L drop of 
vitrification solution two (Appendix B) under mineral oil and remained there for 45 seconds. 
   
  
25 
Next, oocytes were placed in the dilution solution (Appendix B) for 5 minutes. Following the 
dilution solution, oocytes were transferred to a warmed holding medium, HEPES-TALP 
(Appendix A- Protocol A), until entering the Streptomyces griseus protease solution. Dulbecco’s 
phosphate buffered saline was used as the control, and control treatment oocytes followed the 
same protocol as the cryoprotectant exposed oocytes. Next, the oocytes were transferred to a 50 
L drop of 0.1% Streptomyces griseus protease solution (Appendix B) under mineral oil where 
they remained until complete zona digestion was observed. Time of exposure to protease until 
complete zona pellucida digestion was recorded for each individual oocyte.  
Experiment Two Design 
Oocytes were shipped in maturation media consisting of supplemented M199 (Appendix 
B) and allowed to mature for 22 hours within a 5% CO2 incubator. After 22 hours, they were 
vortexed in 1 mg/mL hyaluronidase solution to remove cumulus cells and placed in a warmed 
holding medium, HEPES-TALP (Appendix B), until entering the vitrification protocol. Oocytes 
were first exposed to a 50 L drop of vitrification solution one (Appendix B) under mineral oil 
and remained there for 5 minutes. Immediately afterwards, the oocytes were transferred to a 50 
L drop of vitrification solution two (Appendix B) under mineral oil and remained there for 45 
seconds. Within the allotted 45 seconds for vitrification solution 2, oocytes were placed on a 
cryolock and plunged into liquid nitrogen (Appendix A- Protocol B). All oocytes were warmed 
within 7 days of vitrifying. To begin the thawing process, oocytes were removed from liquid 
nitrogen storage and plunged directly into the warmed dilution solution (Appendix B) for 5 
minutes. Following the dilution solution, oocytes were transferred to a warmed holding medium, 
HEPES-TALP (Appendix A- Protocol A), until entering the Streptomyces griseus protease 
solution. Dulbecco’s phosphate buffered saline was used as the control, and the control treatment 
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oocytes followed the same protocol as the cryoprotectant exposed oocytes. Next, the oocytes 
were transferred to a 50 L drop of 0.1% protease solution under mineral oil where they 
remained until complete zona pellucida digestion was observed. Time of exposure to protease 
until complete zona pellucida digestion was recorded for each individual oocyte. 
 
Table 3.1 Composition of Cryoprotectant Solutions for Fresh and Vitrified Oocytes 
Vitrification Solutions for DMSO Treatment Vitrification Solutions for Glycerol Treatment 
Vitrification One Vitrification Two Vitrification One Vitrification Two 
PBS PBS PBS PBS 
20% Calf Serum 20% Calf Serum 20% Calf Serum 20% Calf Serum 
10% Ethylene Glycol 20% Ethylene Glycol 10% Ethylene Glycol 20% Ethylene Glycol 
10% DMSO 20% DMSO 10% Glycerol 10% Glycerol 
0.5 M Sucrose 0.5 M Sucrose 0.5 M Sucrose 0.5 M Sucrose 
 
 
Preparation of Media 
 Required media included HEPES-TALP (Appendix B), DMSO vitrification solutions one 
and two (Table 3.2), glycerol vitrification solution one and two (Table 3.2), dilution solution 
(Appendix B), and protease solution (Appendix B) were prepared approximately three hours 
prior to time of use. HEPES-TALP holding media for the treatment and control groups consisted 
of 20 mL HEPES-TL (Caisson Labs, North Logan, UT, USA) with 60 mg BSA and 200 L 
sodium pyruvate and pen/strep (Gibco, No. 15140). Two hours prior to oocyte vitrification, all 
necessary media dishes were prepared with the premade solutions in petri dishes (35mm, BD 
 
   
  
27 
Falcon). All media except HEPES-TALP were covered in mineral oil. HEPES-TALP and the 
dilution solution were equilibrated for at least two hours on a warming plate at 37C before 
being used.  
 Vitrification and Warming Procedures 
 Oocytes were exposed to dimethyl sulfoxide, glycerol and control treatment groups in 
both experiments. In each replication, the oocytes were randomly assigned to a treatment group. 
Groups of two to five oocytes would be placed into the designated vitrification solution for 5 
minutes. They were then transferred to the higher concentration vitrification solution and 
removed within 45 seconds. In the first experiment using fresh oocytes, after the higher 
concentration vitrification solution, they were immediately plunged into the dilution solution 
where they remained for 5 minutes. After being removed from the dilution solution (Appendix 
B), oocytes were briefly washed in HEPES-TALP and transferred to the protease solution 
(Appendix B). In the second experiment using vitrified, after the higher concentration 
vitrification solution, the oocytes were placed on the cryolock device, excess media removed and 
plunged into liquid nitrogen within 45 seconds. The caps of the cryolocks were pre-cooled in 
liquid nitrogen and were put on with pre-cooled forceps. The cryolocks were stored in liquid 
nitrogen for no more than 7 days. Upon thawing, the cryolocks were plunged into dilution 
solution where they remained for 5 minutes. Oocytes were then briefly washed in HEPES-TALP 
and transferred to the protease solution for complete zona pellucida digestion. 
Zona Pellucida Digestion 
All oocytes in both experiments were placed in 50 L drops of a 0.1% Streptomyces 
griseus protease solution under mineral oil at room temperature. They remained in the protease 
solution until the zona pellucida was completely digested.  
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Statistical Analysis 
The first experiment consisted of 5 replicates with 41 oocytes each in the DMSO and 
glycerol treatment groups and 35 oocytes in the control group. The second experiment consisted 
of 3 replicates with 37 oocytes in the DMSO treatment group, 41 in the glycerol treatment group, 
and 36 in the control group. Assessment of zona hardening was based on time the oocytes time 
of expose to protease until the zona pellucida had been completely digested. The data was 
analyzed with Sas 9.4, using Least Squares Means and contrasts statements. Values with a P  
0.05 were considered statistically significant.  
RESULTS 
 Experiment One 
 Results from the protease digestion of the zona pellucida using fresh mature oocytes 
showed a statistically significant difference between DMSO, glycerol and PBS treatments with 
the P-value of P= 0.0142. When comparing DMSO digestion to glycerol digestion, there was 
statistical significance with P=0.0238. However, there was no statistical significance when 
comparing DMSO and PBS (P=0.3325). Glycerol compared to PBS showed a statistical 
significant difference with P=0.0058. Lastly, when comparing DMSO and glycerol together to 
PBS, results showed it was statistically significant with P=0.0262 (Table 3.5). The treatments 
DMSO, glycerol, and PBS had an average digestion time of 16.79 minutes, 20.94 minutes, and 
15.2 minutes, respectively. Figure 3.1 shows oocytes at different stages throughout zona 
pellucida digestion: A) after removal from maturation media consisting of supplemented M199, 
3 oocytes are surrounded by cumulus cells; B) a denuded oocyte with a thick, fully intact zona 
pellucida; C) oocyte is approximately half way through protease digestion with thinning of the 
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zona pellucida; D) zona pellucida has completely digested and only the vitelline membrane 
surrounds the nuclear contents.  
 
Table 3.2 Zona Pellucida Mean Protease Digestion Time using Fresh Oocytes 
Treatment N Digestion Time 
DMSO 41 16.79  2.6272 
Glycerol 41 20.94  2.6272 
DPBS 35 15.2  2.6552 
 Standard Deviation 
 
Table 3.3 Comparison of Zona Pellucida Protease Digestion Time between Treatments using 
Fresh Oocytes 
 
Cryoprotectant P value 
DMSO vs. Glycerol 0.0238 
DMSO vs. Control (PBS) 0.3325 
Glycerol vs. Control (PBS) 0.0058 
DMSO & Glycerol vs. Control (PBS) 0.0262 
* Contrasts with a probability value of P0.05 were considered significantly significant 
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Figure 3.2 Stages of Zona Pellucida Digestion by Protease 
 
 
 
 
A- Cumulus-oocyte-complex 
B- Denuded oocyte 
C- Partial zona pellucida digestion 
D- Full zona pellucida digestion 
 
Experiment Two 
 Results from the protease digestion of the zona pellucida using vitrified mature oocytes 
showed no statistical significant difference between DMSO, glycerol and PBS treatments 
(P=0.3437). When comparing DMSO digestion to glycerol digestion there was no statistical 
significance (P=0.5301). DMSO versus the control and glycerol versus the control both showed 
no statistical significance with P-values of P=0.1699 and 0.3813, respectively. Lastly, when 
comparing DMSO and glycerol together to PBS, results showed it was also not statistically 
significant with P=0.2004 (Table 3.6). The treatments DMSO, glycerol, and PBS had an average 
A B 
D C 
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digestion time of 22.78 minutes, 19.56 minutes, and 14.94 minutes, respectively. Figure 3.1 
shows oocytes at different stages throughout zona pellucida digestion: A) after removal from 
maturation media consisting of supplemented M199, 3 oocytes are surrounded by cumulus cells; 
B) a denuded oocyte with a thick, fully intact zona pellucida; C) oocyte is approximately half 
way through protease digestion with thinning of the zona pellucida; D) zona pellucida has 
completely digested and only the vitelline membrane surrounds the nuclear contents.  
 
Table 3.4 Zona Pellucida Mean Protease Digestion Time using Vitrified Oocytes 
Treatment N Digestion Time 
DMSO 37 22.28  4.9906 
Glycerol 41 19.56  5.0011 
DPBS 36 14.94  4.9951 
 Standard Deviation 
 
Table 3.5 Comparison of Zona Pellucida Protease Digestion Time between Treatments using 
Vitrified Oocytes 
 
Cryoprotectant P value 
DMSO vs. Glycerol 0.5301 
DMSO vs. Control (PBS) 0.1699 
Glycerol vs. Control (PBS) 0.3818 
DMSO & Glycerol vs. Control (PBS) 0.2004 
* Contrasts with a probability value of P<0.05 were considered significantly different 
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Figure 3.3 Protease Digestion of the Zona Pellucida using Fresh and Vitrified Oocytes  
 
 
DISCUSSION 
 The aim of these experiments was to determine if zona pellucida hardening is affected by 
choice of cryoprotectant in the cryopreservation of mature oocytes via vitrification. Determining 
which cryoprotectants have the greatest effect on zona pellucida hardening in the vitrification of 
bovine oocytes would be beneficial because it would potentially increase fertilization rates and 
have positive implications regarding the largely unsuccessful efforts of bovine intracytoplasmic 
sperm injection. Without zona pellucida hardening during cryoprotectant exposure, activation of 
the oocyte after ICSI would enable the cortical granule reaction to have the greatest effect on the 
zona pellucida. Within these experiments, progress was made towards determining which 
cryoprotectants would minimize the amount of zona pellucida hardening in bovine vitrification. 
 In the first experiment, significance between all three treatment groups was observed 
(P=0.0142). In the first comparison, zona hardening was statistically different (P=0.0238) when 
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DMSO and glycerol were compared to each other. However, significance was not observed 
when DMSO was compared to the control (P=0.3325), suggesting that DMSO did not harden the 
zona pellucida compared to the control (PBS). Comparing zona hardening in glycerol to the 
control showed the greatest significance (P=0.0058) of all the comparisons. When DMSO and 
glycerol zona digestion observations were combined and compared to the control, zona 
hardening showed to statistically different (P=0.062). All of these data support our hypothesis 
that glycerol hardens the zona pellucida more than DMSO, suggesting that DMSO is the superior 
cryoprotectant in the cryopreservation of bovine oocytes. 
 It has been documented that when mouse and human oocytes are exposed to 
cryoprotectants during cryopreservation there is a rise in intracellular calcium, prematurely 
inducing the cortical granule reaction, subsequently hardening the zona pellucida. Morley and 
Whitfield reported that DMSO caused an intracellular calcium rise in various cell lines (Morley 
and Whitflield, 1993). Premature intracellular calcium rise has not been studied in bovine 
oocytes and should be an important area of interest in research going forward. Utilizing 
fluorescence microscopy to evaluate calcium fluctuations as a result of oocyte exposure to 
cryoprotectants will provide insightful information as to which cryoprotectants have the most 
significant impact on zona pellucida hardening. In a study conducted by Hardin and colleagues, 
deleterious trends from cryoprotectants used in vitrification protocols had negative effects on the 
oocytes ability to repair the metaphase spindles and other organelle disruptions after 
cryopreservation (Hardin et al., 2016). In 1977, Fahy and Karow showed that damage after 
freezing and thawing in certain cases is actually correlated with the concentration of 
cryoprotectants (Fahy and Karow, 1977). Since there is not a universal cryopreservation protocol 
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for vitrifying bovine oocytes, using an alternate protocol with different concentrations of 
cryoprotectants could produce different results.  
 In experiment two, we did not find significance between the three treatment groups 
(P=0.3437). There was no statistical difference in any of the comparisons made: DMSO versus 
glycerol (P=0.5301); DMSO versus control (P=0.1699); glycerol versus control (P=0.3818); or 
DMSO and glycerol versus control (P=0.2004). These results suggest that the cryoinjury due to 
vitrification caused too great of a variability in the zona pellucida digestion time in order for the 
effect of cryoprotectant to be efficiently measured. Our hypotheses could neither be accepted nor 
rejected upon analysis of this data from this experiment. Although we did not find significance, 
there is a trend that both DMSO and glycerol cause an increase in zona pellucida digestion time 
compared to PBS.  
 Damage to oocytes during vitrification has been well documented in many studies, which 
can include premature cortical granule release, zona pellucida hardening, depolymerization of 
the microtubules, and misalignment of the chromosomes. Previous experiments have shown that 
vitrification has negative effects on spindle morphology and other organelle morphology in 
mature oocytes (Purohit, 2012) and could possibly be affecting the mature oocytes after 
vitrification in this experiment. Most importantly, the mechanism of meiotic spindle regeneration 
after oocyte cryopreservation is essentially unknown (Ma, 2010). Al-Hasani and Gook 
demonstrated that cryopreservation induced zona pellucida hardening and premature release of 
the cortical granule content (Al-Hasani, 1987; Gook, 1993). Any and all of these cryoinjuries 
could have had an effect on the high variability of zona digestion encountered in experiment two.   
 In both experiments, the dilution solution, or warming solution, consisted of PBS, bovine 
calf serum, and sucrose. Warming can be defined as the conversion of a glass to a highly viscous 
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supercooled liquid. Studies conducted by several research teams showed that large 
macromolecules such as calf serum are responsible for excessive lipid accumulation through 
increased lipid uptake from the medium and/or through disturbance of mitochondria metabolism, 
which increases oocyte cryosensitivity. (Leroy et al., 2005; Abe et al., 2002). Physical changes of 
lipids submitted to freezing temperatures are among the major causes of cellular cryodamage 
(Pereira and Marques, 2008). However, Shinsuke and Mazur propose that the degree of 
cryoinjury or survival of the oocyte is almost entirely dependent on the warming rate: the faster 
the warming rate, the higher the survival (Shinsuke and Mazur, 2009). If any ice crystallization 
occurs during freezing, oocytes will possibly have already been irreversibly injured, and could 
render the thawing process ineffective. This also could be a potential explanation as to why we 
encountered such high variability in zona pellucida digestion times among the cryoprotectants.  
The structure of DMSO could also have affected the zona pellucida digestion time after 
vitrification. Dimethyl sulfoxide’s structure is quite different that glycerol in that it contains a 
sulfoxide group. Zona proteins 3 of the zona pellucida contains disulfide bridges (Mitchell, 
2014). In theory, the sulfoxide group of DMSO could form disulfide links with ZP3 producing 
intermolecular bonds. If this is happening during vitrification, this could be affecting zona 
pellucida hardening, possibly changing zona pellucida permeability or structure. This also offers 
an explanation as to why there was an increase in zona pellucida digestion time after vitrification 
in DMSO. 
 When comparing the mean zona pellucida digestion times of each treatment between 
experiment 1 and experiment 2 (Figure 3.2), we observed a significant increase in DMSO. In 
experiment 1, the mean digestion time was 16.79 minutes and in experiment 2 was 22.78 
minutes. DMSO was the only treatment group that showed an increase in digestion times, 
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suggesting that vitrification caused the cortical granule reaction, subsequently, hardening of the 
zona pellucida. In glycerol and PBS, a slight decrease was observed in mean digestion time: 
20.94 minutes to 19.56 minutes and 15.2 minutes to 14.94 minutes, respectively. The decrease in 
mean digestion time after vitrification suggests that there was no cortical granule reaction, and 
therefore, the oocytes were not viable after vitrification. The high variability encountered in 
experiment 2 is likely due to the variability of survival. Some oocytes had the cortical granule 
and some did not.  
 Overall, from the first experiment, we can conclude that glycerol should not be used as a 
cryoprotectant for vitrification in bovine oocytes. Although we did not find significance, we 
observed a trend that DMSO possibly causes zona pellucida hardening. Even though cryoinjury 
caused high variability in our attempts to measure zona pellucida hardening after vitrification, we 
believe our results show that the cryoprotectants used in vitrification bears further investigation 
regarding zona pellucida hardening.  
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CHAPTER IV 
SUMMARY AND CONCLUSION 
SUMMARY 
 Oocyte cryopreservation is an attractive option to a number of industries including 
preservation of valuable cell lines, human infertility, livestock production and endangered 
species. All of these areas depend on the successful storage and subsequent viability of 
cryopreserved oocytes. To ensure high levels of cell viability post thaw, cryoprotectants are used 
to lower freezing temperature, allowing for greater dehydration of cells to prevent intracellular 
ice formation (Watson, 1995). Especially in vitrification, the ultra-fast freezing method that 
transforms liquid into a glass-like structure instead of forming ice crystals, high concentrations of 
cryoprotectants are needed to circumvent the rapid decrease in cooling temperatures, which can 
be toxic to oocytes. Therefore, cryoprotectant toxicity can be seen as the most limiting factor for 
the success of cryopreservation by vitrification (Fahy, 2009). The most pertinent cryoinjury in 
bovine oocytes from the cryoprotectants in vitrification is zona hardening. Zona hardening is 
brought about by the fusion of cortical granules to the plasma membrane and the release of their 
contents into the zona pellucida layers (exocytosis) (Sun, 2003). The membrane fusion event is 
calcium-dependent and is normally triggered by the increase in intracellular calcium initiated by 
sperm-egg fusion (Kline and Kline, 1992). However, it has been documented that oocyte and/or 
embryo exposure to cryoprotectants during cryopreservation causes a rise in intracellular 
calcium, prematurely inducing the cortical granule reaction. Depending on the source consulted, 
there have been variable results on the relative toxicity of the different cryoprotectants, with 
disagreement on which is the least or most toxic (Lawson and Sambanis, 2011). Since 
intracytoplasmic sperm injection is largely unsuccessful in the bovine species, evaluating zona 
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pellucida hardening in mature bovine oocytes could further our insight on determining an 
optimal cryoprotectant and concentration for the vitrification of bovine oocytes.  
CONCLUSION 
 The data in the first experiment shows that glycerol hardens the zona pellucida 
significantly more than DMSO or the control. While we could not definitively determine if 
DMSO hardens the zona pellucida more than the control, we observed trends that with further 
research and increase in sample size, could support the hypothesis that DMSO hardens the zona 
pellucida more than the control. Even though our efforts were unsuccessful in further showing 
that cryoprotectants effects on zona pellucida hardening in experiment two, the results were 
useful in suggesting that the cryoinjury caused by vitrification could have more negative effects 
on oocytes than we fully comprehend. Many aspects of cryopreservation are still not fully 
understood, which prompts further imperative research into cryoprotectants, optimal protocols, 
and other factors affecting the complete restoration of structure and function in the mature 
bovine oocyte after thawing. 
 Future research is needed on the varying cryoprotectants and their effects on zona 
pellucida hardening in mature bovine oocytes. More specifically, on the cryoprotectant induced 
premature intracellular calcium rise. In human and mouse oocytes, exposure of oocytes to 
cryoprotectants prior to freezing causes a rise in intracellular calcium, therefore activating 
significant premature exocytosis of cortical granules, in turn stimulating zona hardening (Fuku, 
1995). The premature cortical reaction could explain the poor efficiency of oocyte freezing 
because the oocyte has already begun its activation events and possible down regulation of cell 
cycle control proteins (Larman et al., 2006). In bovine oocytes, very minute amounts of research 
have been conducted regarding zona pellucida hardening and essentially none on intracellular 
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calcium rise. Because intracytoplasmic sperm injection is immensely problematic in bovine 
oocytes, preventing zona pellucida hardening would undoubtedly increase the efficacy of this 
technique.  
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APPENDIX A 
PROTOCOLS 
 
Vitrification of Bovine Oocytes- Protocol A 
1. Prepare equilibration and vitrification solutions before beginning (Appendix B). 
2. Place 3-5 oocytes in 50 L drop of equilibration solution (solution one) under mineral oil 
for 5 minutes, pipette oocytes up, down, and around the dish for continued time during 
the 5 minute interval. 
3. After 5 minutes in the first solution, move oocytes to second solution (50 L drop under 
mineral oil) for 30 seconds, pipetting them around the dish. 
4. In the last 15 seconds of a total of 45 seconds in the second solution, remove oocytes 
from the second solution and place on the tip of a cryolock with minimal media. 
5. Continue immediately to Warming Protocol A. 
 
Vitrification of Bovine Oocytes- Protocol B 
1. Prepare equilibration and vitrification solutions before beginning (Appendix B). 
2. Place 3-5 oocytes in 50 L drop equilibration solution (solution one) under mineral oil 
for 5 minutes, pipette oocytes up, down, and around the dish for continued time during 
the 5 minute interval. 
3. After 5 minutes in the first solution, move oocytes to second solution (50 L drop under 
mineral oil) for 30 seconds, pipetting them around the dish. 
4. In the last 15 seconds of a total of 45 seconds in the second solution, remove oocytes 
from the second solution and place on the tip of a cryolock with minimal media. 
5. After oocytes are placed on the tip of the cryolock and excess media removed, plunge 
cryolock into liquid nitrogen. 
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6. With previously cooled forceps, gently secure the cap, that is also previously cooled, onto 
the cryolock device under the liquid nitrogen. 
7. Move all cryolock with caps into canister for storage. 
8. Repeat until all oocytes have been vitrified.  
9. Continue immediately to Warming Protocol B. 
 
Warming of Bovine Oocytes- Protocol A 
1. Plunge cryolock into dilution solution with oocytes facing upwards, gently moving 
cryolock to remove oocytes. 
2. After 5 minutes in dilution solution, transfer oocytes to warmed HEPES-TALP wash 
medium. 
3. Briefly pipette oocytes up and down in HEPES-TALP and transfer oocytes to protease 
solution. 
 
Warming of Bovine Oocytes- Protocol B 
1. Remove cap from cryolock under liquid nitrogen. 
2. Immediately plunge cryolock into dilution solution with oocytes facing upwards, gently 
moving cryolock to remove oocytes. 
3. After 5 minutes in dilution solution, transfer oocytes to warmed HEPES-TALP wash 
medium. 
4. Briefly pipette oocytes up and down in HEPES-TALP and transfer oocytes to protease 
solution. 
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Protease Digestion of Zona Pellucida 
1. After the HEPES-TALP wash, move oocytes to 50 L drops of protease solution under 
mineral oil. 
2. Oocytes remain in drop until complete zona digestion is observed. 
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APPENDIX B 
MEDIA FORMULATIONS AND STOCK SOLUTIONS 
 Media Formulations: 
 
HEPES-TALP Medium 
Component Source Product Number Amount 
BSA, Fraction V Sigma A-4503 60 mg 
HEPES- TALP Caisson IVL01 20 mL 
Na Pyruvate Stock solution P-4562 200 L 
Pen/Strep Gibco 15140 200 L 
 
 
Maturation Media 
Component Source Product Number Amount 
Medium-199 Sigma M-4530 8.68 mL 
Fetal Bovine Serum Cellgro 35-010-CV 1 mL 
Pen/Strep Gibco 15140 100 L 
Na Pyruvate Stock Solution P-4562 100 L 
Glutamine 100x stock solution G-8540 100 L 
EGF 1000x stock solution E9644 1 L 
FSH (Folltropin) 1000x stock solution Bioniche 10 L 
 
 
Vitrification Solution One for DMSO                   Vitrification Solution Two for DMSO      
PBS 3 mL 
20% Calf Serum 1.0 mL 
10% Ethylene Glycol 0.5 mL 
10 % DMSO 0.5 mL 
0.5 M Sucrose 0.856 g 
  
 
 
Vitrification Solution One for Glycerol       Vitrification Solution Two for Glycerol 
PBS 2 mL 
20% Calf Serum 1.0 mL 
20% Ethylene Glycol 1.0 mL 
20% DMSO 1.0 mL 
0.5 M Sucrose 0.856 g 
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PBS 3 mL 
20% Calf Serum 1.0 mL 
10% Ethylene Glycol 0.5 mL 
10 % Glycerol 0.5 mL 
0.5 m Sucrose 0.856 g 
 
 
Dilution Solution for Warming 
PBS 8 mL 
20% Calf Serum 2 mL 
0.25 M Sucrose 0.856 g 
 
 
Protease Solution for Zona Digestion 
PBS 20 mL 
0.1% Protease 0.02 g  
 
         
  
PBS 2 mL 
20% Calf Serum 1.0 mL 
20% Ethylene Glycol 1.0 mL 
20% Glycerol 1.0 mL 
0.5 M Sucrose 0.856 g 
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Stock Solutions: 
1. Pen/ Strep: Gibco 15140. Aliquot ~ 500 L of new pen/strep solution into sterile 
centrifuge tubes. Store at -20C until use. 
2. Na Pyruvate: Sigma P-4562. Dissolve 22 mg of sodium pyruvate in 10 mL of sterile 
Millipore-Q water. Sterile filter into an aluminum foil-wrapped 15 mL conical tube and 
store at 4C for up to a month. 
3. Hyaluronidase: Sigma H-3506. Prepare a 1mg/mL stock solution by dissolving 10 mg 
hyaluronidase into 10 mL of HEPES-TALP (see media formulations above). Aliquot 1 
mL into 1.5 mL sterile centrifuge tubes. Store at -80C indefinitely.  
4. Protease: Sigma P8811-1G. Dissolve 0.02 g of protease in 20 mL of PBS. 1 mL aliquot 
of new protease solution into sterile 1.5 mL centrifuge tubes. Store at -20C until use.  
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